Although cystic fibrosis (CF) is the most common autosomal recessive genetic disorder of the white population, there are often delays in diagnosis and hence initiation of treatment. Advances of the past decade have made CF screening feasible using routinely collected neonatal blood specimens and determining immunoreactive trypsinogen (IRT) levels and CF mutations by DNA analyses. The overall goal is to address the hypothesis that early diagnosis of CF through neonatal screening will be medically beneficial without major risks. Medically Beneficial refers to better nutritional and/or pulmonary status, whereas major risks include missed diagnoses, potential iatrogenic medical sequelae, and adverse psychosocial consequences.
Specific aims i nclude assessment of the benefits, risks, costs, and quality of life associated with CF neonatal screening and the delineation of the characteristic epidemiologic features of CF. A comprehensive randomized clinical trial emphasizing early diagnosis as the key variable has been underway since 1985. Nutritional status has been assessed by anthropometric and biochemical methods, and the results have demonstrated significant benefits in the screened group. Answering the important question about a pulmonary outcome will require three more years of follow-up evaluation focused on lung function indices and quantitative chest radiology. The investigators note that if the questions underlying this study are answered favorably, it is likely that neonatal screening using a combination of IRT and DNA tests will become the routine method for identifying new cases of CF and that diagnosis in early infancy will allow prevention of many clinically significant problems such as malnutrition. They further note that if CF neonatal screening is implemented nationally, however, several epidemiologic gaps must be closed, including more precise data on the incidence and course of this disease and determination of risk factors for pulmonary infection. The state that this project will generate that important information.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK034108-14
Application #
2900175
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Program Officer
Mckeon, Catherine T
Project Start
1985-08-01
Project End
2001-03-31
Budget Start
1999-04-01
Budget End
2000-03-31
Support Year
14
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Pediatrics
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Farrell, Philip; FĂ©rec, Claude; Macek, Milan et al. (2018) Estimating the age of p.(Phe508del) with family studies of geographically distinct European populations and the early spread of cystic fibrosis. Eur J Hum Genet 26:1832-1839
Sanders, Don B; Zhang, Zhumin; Farrell, Philip M et al. (2018) Early life growth patterns persist for 12?years and impact pulmonary outcomes in cystic fibrosis. J Cyst Fibros 17:528-535
Levy, H; Nugent, M; Schneck, K et al. (2016) Refining the continuum of CFTR-associated disorders in the era of newborn screening. Clin Genet 89:539-49
Parker-McGill, Katelyn; Rosenberg, Marjorie; Farrell, Philip (2016) Access to Primary Care and Subspecialty Care After Positive Cystic Fibrosis Newborn Screening. WMJ 115:295-9
Zhang, Zhumin; Lindstrom, Mary J; Farrell, Philip M et al. (2016) Pubertal Height Growth and Adult Height in Cystic Fibrosis After Newborn Screening. Pediatrics 137:
Sanders, Don B; Li, Zhanhai; Laxova, Anita et al. (2014) Risk factors for the progression of cystic fibrosis lung disease throughout childhood. Ann Am Thorac Soc 11:63-72
Rosenfeld, Margaret; Farrell, Philip M; Kloster, Margaret et al. (2013) Association of lung function, chest radiographs and clinical features in infants with cystic fibrosis. Eur Respir J 42:1545-52
Tluczek, Audrey; Becker, Tara; Grieve, Adam et al. (2013) Health-related quality of life in children and adolescents with cystic fibrosis: convergent validity with parent-reports and objective measures of pulmonary health. J Dev Behav Pediatr 34:252-61
Shoff, Suzanne M; Tluczek, Audrey; Laxova, Anita et al. (2013) Nutritional status is associated with health-related quality of life in children with cystic fibrosis aged 9-19 years. J Cyst Fibros 12:746-53
Wells, Janelle; Rosenberg, Marjorie; Hoffman, Gary et al. (2012) A decision-tree approach to cost comparison of newborn screening strategies for cystic fibrosis. Pediatrics 129:e339-47

Showing the most recent 10 out of 52 publications